Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2006

Feb 2, 2006

29777_dirs_2006-02-01_94bf0745-ba67-420b-9e7a-6fc55b5834cc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-12-22

Reporting Person: NEMMERS JOSEPH M (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-12-22 Common shares without par value G 1750 Disposed 63973 Direct
2006-01-30 Common shares without par value M 568 $20.5347 Acquired 64541 Direct
2006-01-30 Common shares without par value M 4198 $27.4328 Acquired 68739 Direct
2006-01-30 Common shares without par value F 2949 $43.00 Disposed 65790 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-01-30 Option (right to buy) $20.5347 M 568 Disposed 2006-02-08 common shares (568) Direct
2006-01-30 Option (right to buy) $27.4328 M 4198 Disposed 2007-02-13 common shares (4198) Direct
2006-01-30 Option (right to buy) $43.00 A 2678 Acquired 2007-02-13 common shares (2678) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 10835 Indirect
Common shares without par value 346 Indirect
Common shares without par value 284 Indirect
Common shares without par value 290 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 30, 2006.

F2: Reporting person disclaims beneficial ownership of all securities held by his sons. The reporting person no longer has a reportable beneficial interest in shares of Abbott common stock held by one of his sons and included in the reporting person's prior ownership reports.

F3: Includes shares acquired under the Abbott Laboratories Dividend Investment and Stock Purchase Plan in transactions exempt from Section 16(b) under Rule 16(a)-11.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.